Munafa Stock Market Course + Intraday & FNO calls 
Aurinia Pharmaceuticals (AUPH) Technical (Analysis) Reports Aurinia Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Aurinia Pharmaceuticals (AUPH)
Technical Analysis Report for USA stock AUPH Aurinia Pharmaceuticals. Dated: 02 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock AUPH Aurinia Pharmaceuticals then click here. or read Experts views on Aurinia Pharmaceuticals or Forecast & share price targets of Aurinia Pharmaceuticals
Aurinia Pharmaceuticals Opened at 16.06 and Closed at: 15.83, which is -0.76% of previous session's close. It moved within a range of 15.74 and 16.06
The session was a Bearish session with an average volume of 813400, which is -14.83% of previous session's volumes.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
A Dead cross was found 1 days back on short term averages
Support for tomorrow is 15.63 and resistance for tomorrow is 15.95
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 15.69, 15.56 resistance for tomorrow's hourly charts is 16.01, 16.2
10 Day SMA for Aurinia Pharmaceuticals (AUPH) is 16.36 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Aurinia Pharmaceuticals (AUPH) is 16.38 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Aurinia Pharmaceuticals (AUPH) is 15.99 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 15.99 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Aurinia Pharmaceuticals is 15.56 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Aurinia Pharmaceuticals is at 16.38 and 200 DMA is at 15.56, while 50 DMA and 100 DMA are at 15.99 and 15.99 respectively
Aurinia Pharmaceuticals (AUPH) moving average of 20 SMA is at 16.38 and 20 EMA is at 16.32
| Date | Closing Price | 20 SMA | 20 EMA |
| 02 Fri Oct | 15.83 | 16.38 | 16.32 |
| 01 Thu Oct | 15.95 | 16.39 | 16.37 |
| 30 Wed Sep | 16.20 | 16.41 | 16.41 |
| 29 Tue Sep | 16.42 | 16.4 | 16.43 |
| 28 Mon Sep | 16.52 | 16.39 | 16.43 |
| 25 Fri Sep | 16.44 | 16.38 | 16.42 |
Aurinia Pharmaceuticals (AUPH) moving average of 50 SMA is at 15.99 and 50 EMA is at 16.19
| Date | Closing Price | 50 SMA | 50 EMA |
| 02 Fri Oct | 15.83 | 15.99 | 16.19 |
| 01 Thu Oct | 15.95 | 15.98 | 16.2 |
| 30 Wed Sep | 16.20 | 15.97 | 16.21 |
| 29 Tue Sep | 16.42 | 15.95 | 16.21 |
| 28 Mon Sep | 16.52 | 15.94 | 16.2 |
| 25 Fri Sep | 16.44 | 15.91 | 16.19 |
Aurinia Pharmaceuticals (AUPH) moving average of 100 SMA is at 15.99 and 100 EMA is at 15.94
| Date | Closing Price | 100 SMA | 100 EMA |
| 02 Fri Oct | 15.83 | 15.99 | 15.94 |
| 01 Thu Oct | 15.95 | 15.99 | 15.94 |
| 30 Wed Sep | 16.20 | 15.99 | 15.94 |
| 29 Tue Sep | 16.42 | 15.98 | 15.93 |
| 28 Mon Sep | 16.52 | 15.97 | 15.92 |
| 25 Fri Sep | 16.44 | 15.97 | 15.91 |
Aurinia Pharmaceuticals (AUPH) moving average of 200 SMA is at 15.56 and 200 EMA is at 15.13
| Date | Closing Price | 200 SMA | 200 EMA |
| 02 Fri Oct | 15.83 | 15.56 | 15.13 |
| 01 Thu Oct | 15.95 | 15.56 | 15.12 |
| 30 Wed Sep | 16.20 | 15.56 | 15.11 |
| 29 Tue Sep | 16.42 | 15.56 | 15.1 |
| 28 Mon Sep | 16.52 | 15.56 | 15.09 |
| 25 Fri Sep | 16.44 | 15.55 | 15.08 |
Vericel Corporation has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Vericel Corporation, about 1.45% more returns!
Aurinia Pharmaceuticals has performed better than Syndax Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Repligen Corporation has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Repligen Corporation, about 9.96% more returns!
Aurinia Pharmaceuticals has performed better than Pulse Biosciences in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Phio Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Outlook Therapeutics in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Ocular Therapeutix in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Neurocrine Biosciences in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Lexicon Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Kiniksa Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Guardant Health has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Guardant Health, about 11.7% more returns!
Aurinia Pharmaceuticals has performed better than Eyegate Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Cytomx Therapeutics in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Collplant Holdings in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Biogen Inc has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Biogen Inc, about 1.12% more returns!
Aurinia Pharmaceuticals has performed better than Tenet Healthcare in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Mckesson Corporation has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Mckesson Corporation, about 0.92% more returns!
Charles River has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Charles River, about 2.14% more returns!
Aurinia Pharmaceuticals Technical analysis of indicators
Price action analysis of Aurinia Pharmaceuticals (AUPH) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Aurinia Pharmaceuticals in short term but the sell signal is initial and weak.
Aurinia Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aurinia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.35 and Aurinia Pharmaceuticals AUPH stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aurinia Pharmaceuticals AUPH stock. Volume based technical analysis of Aurinia Pharmaceuticals AUPH stock is negative.
Aurinia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock AUPH Aurinia Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AUPH Experts View which covers a lot of information including buying and selling signals
AUPH future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Aurinia Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Aurinia Pharmaceuticals (AUPH) Technical (Analysis) Reports Aurinia Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
